Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume 54, Issue 8, Pages 2132-2142
Publisher
Springer Nature
Online
2011-05-11
DOI
10.1007/s00125-011-2170-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- C-C Chemokine Receptor 2 (CCR2) Regulates the Hepatic Recruitment of Myeloid Cells That Promote Obesity-Induced Hepatic Steatosis
- (2010) A. E. Obstfeld et al. DIABETES
- Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance
- (2010) F. W. Kiefer et al. DIABETES
- Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis
- (2010) Wing-Kin Syn et al. HEPATOLOGY
- Kupffer cell activation is a causal factor for hepatic insulin resistance
- (2009) Nicolas Lanthier et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2009) W. Huang et al. DIABETES
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
- (2009) Elisa Fabbrini et al. HEPATOLOGY
- Kupffer cells promote hepatic steatosis via interleukin-1β-dependent suppression of peroxisome proliferator-activated receptor α activity
- (2009) Rinke Stienstra et al. HEPATOLOGY
- Kupffer cells in non-alcoholic fatty liver disease: The emerging view
- (2009) György Baffy JOURNAL OF HEPATOLOGY
- Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy
- (2009) Emmanuel A. Tsochatzis et al. MEDIATORS OF INFLAMMATION
- The role of osteopontin in d-galactosamine-induced liver injury in genetically obese mice
- (2009) Hyo-Jung Kwon et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Inactivation of Hepatic Foxo1 by Insulin Signaling Is Required for Adaptive Nutrient Homeostasis and Endocrine Growth Regulation
- (2008) Xiaocheng C. Dong et al. Cell Metabolism
- Elevated Expression of Osteopontin May Be Related to Adipose Tissue Macrophage Accumulation and Liver Steatosis in Morbid Obesity
- (2008) A. Bertola et al. DIABETES
- Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects
- (2008) Kevin M. Korenblat et al. GASTROENTEROLOGY
- Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome
- (2008) Paul D. Berk HEPATOLOGY
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
- (2008) Catherine Postic et al. JOURNAL OF CLINICAL INVESTIGATION
- Thematic Review Series: Glycerolipids.DGAT enzymes and triacylglycerol biosynthesis
- (2008) Chi-Liang Eric Yen et al. JOURNAL OF LIPID RESEARCH
- Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice
- (2008) I. Murano et al. JOURNAL OF LIPID RESEARCH
- Osteopontin Expression in Human and Murine Obesity: Extensive Local Up-Regulation in Adipose Tissue but Minimal Systemic Alterations
- (2007) Florian W. Kiefer et al. ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started